Atlas Trials

A Study of the Investigational Monoclonal Antibody, VYD2311, in Healthy Participants

Clinical trial NCT06523153 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06523153
Sponsor
Invivyd, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2024-08-28
Primary completion
2025-05-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.